- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Indian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
UPDATED Oct 26, 2023
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
14 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NATCOPHARMNATCO Pharma | ₹793.60 | -4.8% | 31.4% | ₹142.1b | ₹831.67 | PE17.4x | E23.4% | 0.7% | ||
| AMIORGAmi Organics | ₹1,128.10 | -5.5% | 18.5% | ₹41.6b | ₹1,463.25 | PE48.9x | E24.0% | 0.3% | ||
| AARTIPHARMAarti Pharmalabs | ₹386.95 | -3.2% | n/a | ₹35.1b | n/a | PE18.6x | n/a | 0% | ||
| SOLARASolara Active Pharma Sciences | ₹303.40 | -8.7% | -26.6% | ₹10.9b | ₹407.00 | PB0.7x | E146.1% | 0% | ||
| 506260Anuh Pharma | ₹129.50 | -0.5% | 44.7% | ₹6.5b | n/a | PE16x | n/a | 1.5% | ||
| 526953Venus Remedies | ₹241.30 | -6.4% | 12.8% | ₹3.2b | ₹307.00 | PE15.5x | n/a | 0% | ||
| 532637Mangalam Drugs & Organics | ₹100.80 | -8.4% | -27.9% | ₹1.6b | n/a | PB1x | n/a | 0% | ||
| 524663Bharat Immunologicals & Biologicals | ₹22.95 | -5.1% | -6.5% | ₹991.0m | n/a | PS2.2x | n/a | n/a | ||
| 506128Parnax Lab | ₹86.15 | -6.6% | 11.4% | ₹989.5m | n/a | PE9.9x | n/a | n/a | ||
| 524506Coral Laboratories | ₹267.25 | -9.1% | 6.3% | ₹954.8m | n/a | PE14.2x | n/a | 0% | ||
| 540694ANG Lifesciences India | ₹65.82 | -8.0% | -54.6% | ₹859.5m | n/a | PB1x | n/a | 0% | ||
| 530317Godavari Drugs | ₹85.99 | -4.8% | 25.8% | ₹647.5m | n/a | PE17.6x | n/a | n/a | ||
| 524606Beryl Drugs | ₹22.57 | -6.0% | 137.6% | ₹114.5m | n/a | PE10.6x | n/a | n/a | ||
| 524414Norris Medicines | ₹11.00 | -3.5% | -17.4% | ₹110.0m | n/a | PS1.3x | n/a | n/a |
Page 1 of 1